Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02276560 · ClinicalTrials.gov registry record · Phase 2
Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC
A Phase 2 study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT02276560: Clinical Trial Phase 2 study, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT02276560 is a Phase 2 study that was terminated before completion, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02276560, a Phase 2 study, was terminated before completion, sponsored by UNC Lineberger Comprehensive Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine whether giving cisplatin and nab-paclitaxel before surgery will reduce the presence of disease in certain areas of the lung at the time of surgery.
Primary Outcome
N2 disease is defined as involvement of the ipsilateral mediastinal and/or subcarinal lymph nodes; if disease is cleared form these locations, then there is N2 nodal clearance
Interventions
- DRUG Neoadjuvant Cisplatin, nab-paclitaxel
- DRUG Adjuvant Cisplatin,nab-paclitaxel
- DRUG Adjuvant cisplatin+pemetrexed or cisplatin+gemcitabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-06 |
| Phase | Phase 2 |
Why NCT02276560 stopped before completion
NCT02276560 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Neoadjuvant Cisplatin, nab-paclitaxel is the first listed.
NCT02276560 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02276560 about?
NCT02276560 is a clinical study titled "Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC". The purpose of this research study is to determine whether giving cisplatin and nab-paclitaxel before surgery will reduce the presence of disease in certain areas of the lung at the time of surgery.
What is the current status of trial NCT02276560?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2015-01. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02276560?
The interventions under investigation include: Neoadjuvant Cisplatin, nab-paclitaxel (DRUG), Adjuvant Cisplatin,nab-paclitaxel (DRUG), Adjuvant cisplatin+pemetrexed or cisplatin+gemcitabine (DRUG).
Who is sponsoring clinical trial NCT02276560?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02276560's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia